Skip to main content
Livermore
Livermore
ZHEN

Amalgamated Bank

SEC CIK
0000919192
Latest filing
Jul 23, 2026

APLS holding history

Apellis Pharmaceuticals, Inc. in every 13F filed by Amalgamated Bank, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

APLS overviewAll 13F holders of APLSFull Q2 2026 holdings

Shares (Q2 2026)
0
Sold out in Q2 2026
Value
$0
% of portfolio
0.0%
Quarters held
21
Since Q1 2021
Holdings of APLS by Amalgamated Bank, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 20260$00.0%−34,726−100.0%Sold outHolders
Q1 202634,726$1.40M<0.1%+25,990+297.5%AddedHolders
Q4 20258,736$219.0K<0.1%+62+0.7%AddedHolders
Q3 20258,674$196.0K<0.1%+563+6.9%AddedHolders
Q2 20258,111$140.0K<0.1%+866+12.0%AddedHolders
Q1 20257,245$158.0K<0.1%+291+4.2%AddedHolders
Q4 20246,954$222.0K<0.1%−41−0.6%ReducedHolders
Q3 20246,995$202.0K<0.1%00.0%UnchangedHolders
Q2 20246,995$268.0K<0.1%+359+5.4%AddedHolders
Q1 20246,636$390.0K<0.1%−13,821−67.6%ReducedHolders
Q4 202320,457$1.23M<0.1%−1,728−7.8%ReducedHolders
Q3 202322,185$844.0K<0.1%+763+3.6%AddedHolders
Q2 202321,422$1.95M<0.1%+8,128+61.1%AddedHolders
Q1 202313,294$877.0K<0.1%−2,109−13.7%ReducedHolders
Q4 202215,403$796.0K<0.1%+231+1.5%AddedHolders
Q3 202215,172$1.04M<0.1%+772+5.4%AddedHolders
Q2 202214,400$651.0K<0.1%+1,936+15.5%AddedHolders
Q1 202212,464$633.0K<0.1%−87−0.7%ReducedHolders
Q4 202112,551$593.0K<0.1%+997+8.6%AddedHolders
Q3 202111,554$381.0K<0.1%−711−5.8%ReducedHolders
Q2 202112,265$775.0K<0.1%+3,715+43.5%AddedHolders
Q1 20218,550$367.0K<0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.